68-6

74/104

) Asai T: Commentary: The more, the better? J Thorac Cardiovasc Surg, 2020; S0022-5223: 33214-1.) Hachiro K, Kinoshita T, Suzuki T, Asai T: Total arch replacement in patients with chronic kidney disease. J Card Surg, 2020. doi: 10. 1111/jocs.15219.) Hachiro K, Kinoshita T, Suzuki T, Asai T: Bilateral internal thoracic artery grafting in haemodialysis patients with diabetic nephrop-athy. Interact Cardiovasc Thorac Surg, 2020; 31: 774-780.) Honzawa A, Nishitani-Yokoyama M, Shimada K, Kunimoto M, Yamada M, Matsubara T, Matsumori R, Fujiwara K, Abulimiti A, Aikawa T, Ouchi S, Shimizu M, Sugita Y, Shimada A, Yamamoto T, Amano A, Asai T, Saito M, Morisawa T, Takahashi T, Fujiwara T, Daida H, Minamino T: Relationship Between Kihon Checklist Score and Anxiety Levels in Elderly Patients Undergoing Early Phase II Cardiac Rehabilitation. Cardiol Res. 2020; 11: 405-411.) Asai T: Commentary: Increased Windkessel effect is a sign of aortic aneurysm. J Thorac Cardiovasc Surg, 2020: S0022-5223: 31758-X.) Enomoto M, Suzuki T, Kinoshita T, Takashima N, Minamidate N, Lee J, Wakisaka H, Asai T: Outcomes of surgical treatment for active infective endocarditis of mitral valve compared using complexity scoring. Gen Thorac Cardio-vasc Surg, 2020. doi: 10.1007/s11748-020-01456-6.) Asai T, Dohi S, Oishi A, Endo D: Commen-tary: There is a type Ia leak in that stent-graft? J Thorac Cardiovasc Surg, 2020: S0022- 5223: 32034-1. Commentary: There is a type Ia leak in that stent-graft? J Thorac Cardio-vasc Surg, 2020; S0022-5223: 32034-1.) Miyashita F, Kinoshita T, Suzuki T, Asai T: Respiratory Failure after Open Descending Aortic Aneurysm Repair: Risk Factors and Outcomes. Ann Thorac Cardiovasc Surg, 2020. doi: 10.5761/atcs.oa.20-00020. ) Nahar N, Kinoshita T, Suzuki T, Miura K, Asai T: Dynamic changes of mitral annulus in patients with degenerative mitral regurgi-tation and chronic atrial fibrillation under-going mitral valve reconstruction. Gen Thorac 638tionship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database: J Hum Genet, 2020; 66: 307-314.doi:10.1038/s10038-020-00849-y. 27) Yoshimura A, Yokoyama S, Iwata H, Takaiso N, Nomizu T, Arai M, Nakamura S: Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consor-tium registration. J Hum Genet, 2020. doi: 10. 1038/s10038-020-00850-5. 28) Inuzuka M, Watanabe C, Yokoyama S, Kuwayama T, Akashi-Tanaka S, Arai M, Nakamura S: Registration Committee of the Japanese HBOC consortium. A Retrospective Analysis of the Relationship between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan. Clin Breast Cancer, 2020; 21: e48-e52. 29) Mitamura T, Sekine M, Arai M, Shibata Y, Kato M, Yokoyama S, Yamashita H, Watari H, Yabe I, Nomura H, Enomoto T, Nakamura S: Registration Committee of the Japanese HBOC Consortium: Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome. Jpn J Clin Oncol, 2020; 50: 1380-1385. 30) Kaneyasu T, Mori S, Yamauchi H, Ohsumi S, Ohno S, Aoki D, Baba S, Kawano J, Miki Y, Matsumoto N, Nagasaki M, Yoshida R, Akashi- Tanaka S, Iwase T, Kitagawa D, Masuda K, Hirasawa A, Arai M, Takei J, Ide Y, Gotoh O, Yaguchi N, Nishi M, Kaneko K, Matsuyama Y, Okawa M, Suzuki M, Nezu A, Yokoyama S, Amino S, Inuzuka M, Noda T, Nakamura S: Prevalence of disease-causing genes in Japa-nese patients with BRCA1/2-wildtype hered-itary breast and ovarian cancer syndrome. NPJ Breast Cancer, 2020; 6: 25. 31) Teraoka S， Sato E， Narui K， Yamada A， Fujita T， Yamada K， Oba M， Ishikawa T: Neoadjuvant Chemotherapy With Anthracy-cline-Based Regimen for BRCAness Tumors in Triple-Negative Breast Cancer． Journal of Surgical Research, 2020; 143-147.Cardiovascular Surgery〈Original Articles〉 1 2 3 4 5 6 7 8 9